OBJECTIVE: Bipolar disorder is frequently misdiagnosed as major depressive disorder (MDD). We aim to quantify the prevalence of misdiagnosed bipolar disorder among the depression population and evaluate the quality-of-life (QOL) impact of misdiagnoses. METHOD: Data were collected from 2 self-administered, cross-sectional studies in 2003. Patients participating in The Bipolar Disorder Misdiagnosis Study (N = 1156) were previously diagnosed with depression, experienced a depressive episode within the past year, and had no previous diagnosis of bipolar disorder or schizophrenia. Patients who experienced a manic episode in the past year, based on DSM-IV criteria, were classified as misdiagnosed. Patients participating in The Bipolar Disorder Project (N = 1214) self-reported a diagnosis of bipolar disorder and were recruited through community mental health centers and support groups. Quality of life was assessed via the Psychological General Well-Being (PGWB) Index and Medical Outcomes Study 8-Item Short-Form Health Survey (SF-8). Demographic differences between groups were controlled using linear regression models. RESULTS: Of the diagnosed MDD sample, 14.3% met criteria for misdiagnosed bipolar disorder. When controlling for demographic differences, the PGWB overall score for the misdiag-nosed averaged 12.77 (p < .001) points lower than that of MDD patients and 9.55 (p < .001) points lower than that of diagnosed bipolar disorder patients. The average SF-8 mental component summary score for the misdiagnosed was 5.85 (p < .001) points lower than that of MDD patients and 3.18 (p = .002) points lower than that of diagnosed bipolar disorder patients. CONCLUSION: Misdiagnosis is associated with poorer QOL than MDD or diagnosed bipolar disorder, which are recognized as having a considerable impact on QOL.
OBJECTIVE:Bipolar disorder is frequently misdiagnosed as major depressive disorder (MDD). We aim to quantify the prevalence of misdiagnosed bipolar disorder among the depression population and evaluate the quality-of-life (QOL) impact of misdiagnoses. METHOD: Data were collected from 2 self-administered, cross-sectional studies in 2003. Patients participating in The Bipolar Disorder Misdiagnosis Study (N = 1156) were previously diagnosed with depression, experienced a depressive episode within the past year, and had no previous diagnosis of bipolar disorder or schizophrenia. Patients who experienced a manic episode in the past year, based on DSM-IV criteria, were classified as misdiagnosed. Patients participating in The Bipolar Disorder Project (N = 1214) self-reported a diagnosis of bipolar disorder and were recruited through community mental health centers and support groups. Quality of life was assessed via the Psychological General Well-Being (PGWB) Index and Medical Outcomes Study 8-Item Short-Form Health Survey (SF-8). Demographic differences between groups were controlled using linear regression models. RESULTS: Of the diagnosed MDD sample, 14.3% met criteria for misdiagnosed bipolar disorder. When controlling for demographic differences, the PGWB overall score for the misdiag-nosed averaged 12.77 (p < .001) points lower than that of MDDpatients and 9.55 (p < .001) points lower than that of diagnosed bipolar disorderpatients. The average SF-8 mental component summary score for the misdiagnosed was 5.85 (p < .001) points lower than that of MDDpatients and 3.18 (p = .002) points lower than that of diagnosed bipolar disorderpatients. CONCLUSION: Misdiagnosis is associated with poorer QOL than MDD or diagnosed bipolar disorder, which are recognized as having a considerable impact on QOL.
Authors: M Tohen; T M Sanger; S L McElroy; G D Tollefson; K N Chengappa; D G Daniel; F Petty; F Centorrino; R Wang; S L Grundy; M G Greaney; T G Jacobs; S R David; V Toma Journal: Am J Psychiatry Date: 1999-05 Impact factor: 18.112
Authors: Joseph R Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen D Wagner Journal: J Clin Psychiatry Date: 2003-04 Impact factor: 4.384
Authors: Andrée M Cusi; Anthony Nazarov; Katherine Holshausen; Glenda M Macqueen; Margaret C McKinnon Journal: J Psychiatry Neurosci Date: 2012-05 Impact factor: 6.186
Authors: Tom Hughes; Alastair Cardno; Robert West; Federica Marino-Francis; Imogen Featherstone; Keeley Rolling; Alice Locker; Kate McLintock; Allan House Journal: Br J Gen Pract Date: 2016-01-06 Impact factor: 5.386
Authors: Reagan Farmer; Steven D Burbano; Neema S Patel; Angelo Sarmiento; Abigail J Smith; Michy P Kelly Journal: Cell Signal Date: 2020-02-29 Impact factor: 4.315
Authors: Chi Ming Leung; Chi Lap Yim; Connie T Y Yan; Cheuk Chi Chan; Yu-Tao Xiang; Arthur D P Mak; Marcella Lei-Yee Fok; Gabor S Ungvari Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240
Authors: Lucas Anyayo; Scholastic Ashaba; Mark Mohan Kaggwa; Samuel Maling; Etheldreda Nakimuli-Mpungu Journal: Health Qual Life Outcomes Date: 2021-03-10 Impact factor: 3.186